European Journal of Clinical Pharmacology

, Volume 31, Issue 5, pp 579–582

Pharmacokinetics of budesonide in children with asthma

  • S. Pedersen
  • G. Steffensen
  • I. Ekman
  • M. Tönnesson
  • O. Borgå


The pharmacokinetics of the glucocorticoid budesonide was studied in 6 children with asthma after i.v. injection of 0.5 mg and oral inhalation of 1 mg as an aerosol. Budesonide is a 1:1 mixture of the epimers 22 S and 22 R, which were assayed separately by HPLC combined with RIA. All pharmacokinetic parameters of the epimers differed except the half-life of about 1.5 h. It was significantly shorter than that reported in adults. Plasma clearance averaged 103 l · h−1 for epimer 22 R and 74 l · h−1 for epimer 22 S; calculated per kg body weight these values were about 50% higher than in adults. The difference was about 40% when calculated per m2 of body surface area. Since budesonide is a high-clearance drug, the data indicate higher liver blood flow · kg−1 body weight and m2 of body surface area in children. The systemic availability of the aerosol was approximately 30% of nominal dose, i.e. the same as in adults. The high clearance and short half-life of budesonide in children are advantageous in reducing the risk of possible systemic side-effects of prophylactic treatment of asthma in childhood.

Key words

budesonide asthma glucocorticoid pharmacokinetics children inhalation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andersson P, Brattsand R, Edsbäcker S, Källström L, Ryrfeldt Å (1982a) Biotransformation rate (in vitro) and systemic potency (in vivo) of the topical glucocorticoid budesonide in male and female rats. J Steroid Biochem 17: 703–706Google Scholar
  2. 2.
    Andersson P, Edsbäcker S, Ryrfeldt Å, von Bahr C (1982b) In vitro biotransformation of glucocorticoids in liver and skin homogenate fraction from man, rat and hairless mouse. J Steroid Biochem 16: 787–795Google Scholar
  3. 3.
    Dahlberg E, Thalén A, Brattsand R, Gustafsson JÅ, Johansson U, Roempke K, Saartok T (1984) Correlation between chemical structure, receptor binding and biochemical activity of some novel, high active 16 α, 17 α-acetalsubstituted glucocorticoids. Mol Pharmacol 25: 70–78Google Scholar
  4. 4.
    Du Bois D, Du Bois EF (1916) Clinical calorimetry X. A formula to estimate the approximate surface if height and weight be known. Arch Intern Med 17: 863Google Scholar
  5. 5.
    Hamilton RA, Garnett WR, Kline BJ (1981) Determination of mean valproic acid serum level by assay of single pooled sample. Clin Pharmacol Ther 29: 408–413Google Scholar
  6. 6.
    Mihaly GW, Moore RG, Thomas J et al. (1978) The pharmacokinetics and metabolism of the anilide local anaestetics in neonates. Eur J Clin Pharmacol 13: 143–152Google Scholar
  7. 7.
    Newman SP (1983) Deposition and effects of inhalation aerosols. Rahms Tryckeri, Lund, SwedenGoogle Scholar
  8. 8.
    Rane A (1980) Basic principals of drug disposition and action in infants and children. In: Yaffe SJ (ed) Pediatric pharmacology. Grune and Stratton, PhiladelphiaGoogle Scholar
  9. 9.
    Ryrfeldt Å, Andersson P, Edsbäcker S, Tönnesson M, Davies DS, Pauwels R (1982) Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 63 [Suppl 122]: 86–95Google Scholar
  10. 10.
    Ryrfeldt Å, Edsbäcker S, Pauwels R (1984) Kinetics of the epimeric glucocorticoid budesonide. Clin Pharmacol Ther 35: 525–530Google Scholar
  11. 11.
    Thalén A, Brattsand R (1979) Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity. Arzneimittelforsch/Drug Res 29: 1687–1690Google Scholar
  12. 12.
    Aherne GW, Littleton P, Thalén A, Marks V (1982) A sensitive radioimmunoassay for budesonide in plasma. J Steroid Biochem 17: 559–565Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • S. Pedersen
    • 1
  • G. Steffensen
    • 1
  • I. Ekman
    • 2
  • M. Tönnesson
    • 2
  • O. Borgå
    • 2
  1. 1.Paediatric DepartmentAalborg HospitalDenmark
  2. 2.Pharmacokinetics LaboratoryAB DracoLundSweden

Personalised recommendations